Applying NGS and Actionable Genomic Alterations to Patients with Lung Cancer: Professor Yang

Applying NGS and Actionable Genomic Alterations to Patients with Lung Cancer: Professor Yang


Published

January 20, 2017

Created by

CMEducation Resources symposium

Related Presenters

James Chih-Hsin Yang, MD, PhD

James Chih-Hsin Yang, MD, PhD

Professor and Director, Graduate Institute of Oncology, NTU Director, Department of Oncology, National Taiwan University Hospital